About Bioline  All Journals  Testimonials  Membership  News  Donations

Zoological Research
Kunming Institute of Zoology, Chinese Academy of Sciences
ISSN: 2095-8137
Vol. 29, No. 6, 2008, pp. 608-612
Bioline Code: zr08093
Full paper language: Chinese
Document type: Research Article
Document available free of charge

Zoological Research, Vol. 29, No. 6, 2008, pp. 608-612

 en Synergetic Inhibition of Bromocrptine and Baclofen on the Naloxone-induced Withdrawal Syndromes
Niu, Hai-chen; Li, Ling; Shang, Bin; Sun, Ning-lei; Guan, Yi-liang; Yu, Hua-lin & Ma, Yuan-ye


Mice were administrated by the consecutive morphine, subcutaneous injection (25, 50, 75, 100, 125, 150 mg/kg)to establish the withdrawal model. The naloxone (6 mg/kg)-induced responses, namely jumping behavior can be observed as withdrawal behavior. Bromocriptine and baclofen were used in the protocol and their synergetic inhibition was also studied. The results suggested that the low dose of bromocriptine (10 mg/kg) can not inhibit the withdrawal syndromes , whereas the mid (20 mg/kg) and high (30 mg/kg) doses can do. The low (0.5 mg/kg) and mid (1.0 mg/kg) doses of baclofen can not decrease the withdrawal syndromes, whereas the high dose can effectively inhibit the nalxone-induced response in the mice. However the co-administration of bromocriptine (10 mg/kg) and baclofen (1.0 mg/kg) can inhibit the withdrawal response. The results showed that the two receptors synergized and effectively inhibited the naloxone-induced withdrawal syndromes.

Bromocrptine; Baclofen; Withdrawal syndromes; Morphine; Synergism; GABA Receptor; DA Receptor

© Copyright 2008 Kunming Institute of Zoology, the Chinese Academy of Sciences
Alternative site location:

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2022, Site last up-dated on 19-Jan-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Internet Data Center of Rede Nacional de Ensino e Pesquisa, RNP, Brazil